Showing results (71-80 of 359) with videos related to
Sort By:
Pageof 36
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Facing the nuclear threat: thyroid blocking revisitedHeribert Hänscheid, Christoph Reiners, Guennadi Goulko, et al.Current Cancer Drug Targets|April 12, 2014
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholineIna Israel, Dominik Richter, Jochen Stritzker, et al.Journal of the South African Veterinary Association|October 18, 2018
Xenotransfusion with packed bovine red blood cells to a wildebeest calf (Connochaetes taurinus)Roxanne K Buck, George F Stegmann, Luke A Poore, et al.Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Radiopharmaceuticals for Treatment of Adrenocortical CarcinomaKerstin Michalski, Wiebke Schlötelburg, Philipp E Hartrampf, et al.Oncotarget|March 9, 2018
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancerHinrich Wieder, Ambros J Beer, Jens Siveke, et al.Nuclear Medicine Communications|August 30, 2014
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?Rudolf A Werner, Christina Bluemel, Constantin Lapa, et al.Medical Physics|May 12, 2017
Internal radionuclide therapy: The ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.Medical Physics|August 27, 2005
Internal radionuclide therapy: the ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapyKerstin Michalski, Juri Ruf, Christian Goetz, et al.Nuklearmedizin. Nuclear Medicine|December 18, 2007
Integrated FDG PET-CT imaging improves staging in malignant pleural mesotheliomaS Krüger, S Pauls, F M Mottaghy, et al.Pageof 36